Skip to main content

Cognitive Change

2
Pipeline Programs
7
Companies
5
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Oregon Therapeutics
Oregon TherapeuticsFrance - Paris
2 programs
2
Sharing History through Active Reminiscence and Photo-imageryPhase 11 trial
Sharing History through Active Reminiscence and Photo-imageryPhase 11 trial
Active Trials
NCT05906654Completed21Est. Jul 2018
NCT05906667Completed23Est. Aug 2020
Plus Therapeutics
1 program
Juice PLUS+® OMEGAN/A1 trial
Active Trials
NCT05581108CompletedEst. Jul 2023
Monteris Medical
Monteris MedicalMN - Minnetonka
1 program
Neuroblate SystemN/A1 trial
Active Trials
NCT05075850Completed81Est. Sep 2023
UCB Pharma
UCB PharmaBelgium - Brussels
1 program
cognitive rehabilitationN/A1 trial
Active Trials
NCT05057156Unknown90Est. Mar 2024

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Oregon TherapeuticsSharing History through Active Reminiscence and Photo-imagery
Oregon TherapeuticsSharing History through Active Reminiscence and Photo-imagery
Plus TherapeuticsJuice PLUS+® OMEGA
UCB Pharmacognitive rehabilitation
Monteris MedicalNeuroblate System

Clinical Trials (5)

Total enrollment: 215 patients across 5 trials

NCT05906667Oregon TherapeuticsSharing History through Active Reminiscence and Photo-imagery

Sharing History Through Active Reminiscence and Photo-imagery - With MCI

Start: May 2017Est. completion: Aug 202023 patients
Phase 1Completed
NCT05906654Oregon TherapeuticsSharing History through Active Reminiscence and Photo-imagery

Sharing History Through Active Reminiscence and Photo-imagery (SHARP) Pilot Program

Start: Feb 2016Est. completion: Jul 201821 patients
Phase 1Completed
NCT05581108Plus TherapeuticsJuice PLUS+® OMEGA

Enhancement of Learning and Memory Following Supplementation With Juice PLUS+® OMEGA in an Adolescent Population

Start: Oct 2021Est. completion: Jul 2023
N/ACompleted
NCT05057156UCB Pharmacognitive rehabilitation

Digital Solution to Improve Cognitive Function in Epilepsy: PRODDIGE Project

Start: Oct 2021Est. completion: Mar 202490 patients
N/AUnknown

PatiEnt Neuropsychological outcomeS After laseR Ablation

Start: Sep 2021Est. completion: Sep 202381 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

7 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.